| Trial Status | Closed for recruitment |
| Dates | Date of activation: 04-Jan-07 Closed on : 12-Jun-09 |
| Data management at EORTC | Full |
| Phase | 2 |
| Randomized trial | Yes |
| Type | Periadjuvant |
| Targeted Sample size | EORTC Groups: 100 - All Groups: 100 |
| Number of steps | 1 |
| Drug | Fluorouracil Bevacizumab Cetuximab Leucovorin Oxaliplatin |
| Study Staff | Bernard Nordlinger (Study Coordinator) - CHU Ambroise Pare AP-HP, Boulogne-Billancourt Murielle Mauer (Statistician) - EORTC Headquarters, Brussels Marie-Ange Lentz (Data Manager) - EORTC Headquarters, Brussels Michel Praet (Project Manager) - EORTC Headquarters, Brussels, michel.praet( at )eortc.be, +32 27741672 |
| Type of cancer | Liver Colorectal |
| Participating Groups | EORTC Gastrointestinal Tract Cancer Group(Coordinating Group) |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | NCT00438737 |
| EudraCT | 2005-002825-29 |
| Protocol documents in PDF (requires password) | Study documentation |